Sorry mate but no-one rings a bell at the bottom Sure 6.00 was a good intermediate term buy. Now its an excellent intermediate term short.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025